ClinicalTrials.Veeva

Menu

Ultrasonography-guided and Surgical Rectus Sheath Block in Single-port Access Laparoscopy

C

Chungnam National University Hospital

Status and phase

Unknown
Phase 2

Conditions

Pain

Treatments

Other: Normal saline
Drug: Ropivacaine
Procedure: Rectus sheath block

Study type

Interventional

Funder types

Other

Identifiers

NCT02431065
GyAne-1

Details and patient eligibility

About

Rectus sheath block is effective in reducing pain in the peri-umbilical region, and the use of ultrasonography is recommended to perform the block at the precise location. Recently, intra-operative rectus sheath block has also been introduced without the aid of ultrasonography. However, no study has not yet compared the analgesic effects of these two different approaches (ultrasonography-guided vs direct surgical). Thus, the aim of our study is to compare the effect of ultrasonography-guided and direct-surgical rectus sheath block after single-port access laparoscopy in benign ovary cyst patients.

Full description

This is a randomized, prospective study comparing the analgesic effects of ultrasonography-guided and direct-surgical rectus sheath block after single-port access laparoscopy in benign ovary cyst patients.

Patients will be randomly divided into 3 groups based on the procedure: control group, ultrasonography group and direct injection group. Each group consists of 30 patients.

  • Control group Normal saline 10mL will be injected under ultrasonography guidance into the right, left rectus sheath at the end of the operation before emergence from general anesthesia.

    • Ultrasonography group Local anesthetic (Ropivacaine 0.75% 10 mL) will be injected under ultrasonography guidance into the right left rectus sheath at the end of the operation before emergence from general anesthesia.

      • Direct injection group Local anesthetic (Ropivacaine 0.75% 10 mL) will be injected under direct visualization into the right, left rectus sheath at the end of the operation before emergence from general anesthesia.

Analgesic efficiency will be assessed using the VAS (visual analogue scale) pain scale and the total amount of self-administered fentanyl via PCA (patient controlled analgesia) devices at multiple time scales (1, 6, 10, 24 and 48 hours after surgery). We will also compare the incidence of fentanyl complications, such as nausea, vomiting, pruritus and dizziness

Enrollment

30 estimated patients

Sex

Female

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients scheduled for a single port laparoscopic surgery at Chung Nam University hospital due to benign tumor of the ovary or the fallopian tube
  2. Between age of twenty to seventy
  3. Patients with a physical rating of 1 or 2 according to the American Anesthesiology guidelines
  4. Patients who have not had laparoscopic surgery within two months

Exclusion criteria

  1. Hysterectomy via single port laparoscopic surgery
  2. Patients with chronic pelvic pain
  3. Abdominal pain of unknown origin
  4. Suspected malignant tumor
  5. Diagnosed with malignant tumor of any origin
  6. Patients currently taking psychiatric medicine
  7. Pregnancy
  8. Patients with a history of hypersensitivity to amide type local anesthetics
  9. Patients with a history of hypersensitivity to opioid
  10. Risk of bleeding
  11. Unable to comprehend or does not agree to the consent form

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 3 patient groups, including a placebo group

Group 3, Direct injection group
Experimental group
Description:
Test group 2, Rectus sheath block will be performed under direct visualization. Ropivacaine (0.75%, 10ml) will be directly injected into the right and left rectus sheath at the end of the operation.
Treatment:
Drug: Ropivacaine
Procedure: Rectus sheath block
Group 2, ultrasonography group
Active Comparator group
Description:
Test group 1, Rectus sheath block will be performed under sonographic guidance. Ropivacaine (0.75%, 10ml) will be injected into the right and left rectus sheath under ultrasonographic guidance at the end of the operation.
Treatment:
Drug: Ropivacaine
Procedure: Rectus sheath block
Group 1
Placebo Comparator group
Description:
Control group, Rectus sheath block will be performed under sonographic guidance. Normal saline 10 ml will be injected into the right, left rectus sheath under ultrasonography guidance at the end of the operation.
Treatment:
Other: Normal saline
Procedure: Rectus sheath block

Trial contacts and locations

0

Loading...

Central trial contact

Heon Jong Yoo

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems